Trellus Health
Financials
Estimates*
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | <1m | <1m | <1m |
% growth | - | (28 %) | 6 % |
EBITDA | (5.9m) | (8.3m) | (5.8m) |
% EBITDA margin | (23480 %) | (45967 %) | (30768 %) |
Profit | (5.9m) | (8.8m) | (6.3m) |
% profit margin | (23608 %) | (48944 %) | (33363 %) |
EV / revenue | 2876.0x | 20.8x | - |
EV / EBITDA | -12.3x | -0.1x | - |
Date | Investors | Amount | Round |
---|---|---|---|
$5.0m | Seed | ||
N/A | N/A | IPO | |
Total Funding | $5.0m |
Recent News about Trellus Health
EditTrellus Health operates in the healthcare sector, focusing on providing support for individuals with chronic conditions, specifically Crohn's Disease and Ulcerative Colitis. The company offers an integrated behavioral health program that combines clinical expertise with a supportive framework to help patients manage their conditions more effectively. Trellus Health serves patients who are struggling with inflammatory bowel diseases (IBD) and aims to reduce their reliance on emergency room visits, hospitalizations, and steroid use. The business model revolves around a subscription-based service where patients gain access to a comprehensive support system, including resilience coaching and connectivity tools that foster a sense of community and empowerment. Revenue is generated through these subscriptions, as well as partnerships with healthcare providers and insurers who recognize the value of reducing overall healthcare costs through improved patient outcomes.
Trellus Health operates primarily in the United States but aims to expand its reach globally. The company's approach is grounded in evidence-based practices, and its effectiveness has been demonstrated in clinical studies.
Keywords: IBD support, behavioral health, chronic conditions, resilience coaching, healthcare, subscription service, patient empowerment, clinical expertise, cost reduction, community support.